299 related articles for article (PubMed ID: 29321047)
1. Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.
Guertin MH; Robitaille K; Pelletier JF; Duchesne T; Julien P; Savard J; Bairati I; Fradet V
BMC Cancer; 2018 Jan; 18(1):64. PubMed ID: 29321047
[TBL] [Abstract][Full Text] [Related]
2. A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.
Robitaille K; Guertin MH; Jamshidi A; Xu HW; Hovington H; Pelletier JF; Beaudoin L; Gevariya N; Lacombe L; Tiguert R; Caumartin Y; Dujardin T; Toren P; Lodde M; Racine É; Trudel D; Perigny M; Duchesne T; Savard J; Julien P; Fradet Y; Fradet V
Commun Med (Lond); 2024 Mar; 4(1):56. PubMed ID: 38519581
[TBL] [Abstract][Full Text] [Related]
3. Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.
Savard J; Moussa H; Pelletier JF; Julien P; Lacombe L; Tiguert R; Caumartin Y; Dujardin T; Toren P; Pouliot F; Lodde M; Fradet Y; Robitaille K; Fradet V
Cancer Med; 2023 Oct; 12(19):20163-20176. PubMed ID: 37787025
[TBL] [Abstract][Full Text] [Related]
4. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
Aronson WJ; Kobayashi N; Barnard RJ; Henning S; Huang M; Jardack PM; Liu B; Gray A; Wan J; Konijeti R; Freedland SJ; Castor B; Heber D; Elashoff D; Said J; Cohen P; Galet C
Cancer Prev Res (Phila); 2011 Dec; 4(12):2062-71. PubMed ID: 22027686
[TBL] [Abstract][Full Text] [Related]
5. Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA).
Moussa H; Robitaille K; Pelletier JF; Tourigny R; Fradet Y; Lacombe L; Toren P; Lodde M; Tiguert R; Dujardin T; Caumartin Y; Duchesne T; Julien P; Savard J; Diorio C; Fradet V
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986098
[TBL] [Abstract][Full Text] [Related]
6. Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy.
Fradet S; Pelletier JF; Singbo N; Lacombe L; Toren P; Lodde M; Dujardin T; Tiguert R; Fradet Y; Robitaille K; Fradet V
Clin Nutr ESPEN; 2022 Feb; 47():221-226. PubMed ID: 35063205
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of ω-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Fulton AS; Hill AM; Williams MT; Howe PR; Frith PA; Wood LG; Garg ML; Coates AM
Trials; 2013 Apr; 14():107. PubMed ID: 23782589
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
12. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
Grenon SM; Owens CD; Nosova EV; Hughes-Fulford M; Alley HF; Chong K; Perez S; Yen PK; Boscardin J; Hellmann J; Spite M; Conte MS
J Am Heart Assoc; 2015 Aug; 4(8):e002034. PubMed ID: 26296857
[TBL] [Abstract][Full Text] [Related]
13. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy.
Kelavkar UP; Hutzley J; Dhir R; Kim P; Allen KG; McHugh K
Neoplasia; 2006 Feb; 8(2):112-24. PubMed ID: 16611404
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial.
Thota RN; Acharya SH; Abbott KA; Garg ML
Trials; 2016 Nov; 17(1):565. PubMed ID: 27894336
[TBL] [Abstract][Full Text] [Related]
16. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
Bosland MC; Kato I; Zeleniuch-Jacquotte A; Schmoll J; Enk Rueter E; Melamed J; Kong MX; Macias V; Kajdacsy-Balla A; Lumey LH; Xie H; Gao W; Walden P; Lepor H; Taneja SS; Randolph C; Schlicht MJ; Meserve-Watanabe H; Deaton RJ; Davies JA
JAMA; 2013 Jul; 310(2):170-8. PubMed ID: 23839751
[TBL] [Abstract][Full Text] [Related]
17. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
McDaniel JC; Rausch J; Tan A
Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
[TBL] [Abstract][Full Text] [Related]
18. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
19. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
20. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
